Looking on the internet deeply has found these results:

please see is the most popular phrase on the web.

please refer to 183,300,000 results on the web	please see 1150,000,000 results on the web More popular!
Some examples and use cases from the internet:	Some examples and use cases from the internet:
For more troubleshooting tips please refer to userbase. kde. org/ Akonadi. For storage information, please refer to Section 5' How to store VFEND'. In this case, please refer to the specific notification form. For elderly patients with reduced renal function please refer to section 4.2. If yes, please refer to point 131 of the Guidelines. For more details, please refer to the Online Price Quotes section. For more information regarding EFSA, please refer to its Founding Regulation: For additional factual details please refer to the opening decision, which should be considered an integral part of this Decision.	In this case, please see below: "Important information about some of the ingredients of Diacomit". For a detailed description of the commitment please see Annex C. For a full description of the dosages, please see the Package Leaflet. For the full description of the side effects reported with Actraphane, please see the Package Leaflet. For the full description of all side effects reported with Corlentor, please see the Package Leaflet. As for sustainability please see response above (c). As regards the role of direct budget support, please see comments to paragraphs 36. 38.

please refer to

183,300,000 results on the web

please see

1150,000,000 results on the web

More popular!

For more troubleshooting tips please refer to userbase. kde. org/ Akonadi.
For storage information, please refer to Section 5' How to store VFEND'.
In this case, please refer to the specific notification form.
For elderly patients with reduced renal function please refer to section 4.2.
If yes, please refer to point 131 of the Guidelines.
For more details, please refer to the Online Price Quotes section.
For more information regarding EFSA, please refer to its Founding Regulation:
For additional factual details please refer to the opening decision, which should be considered an integral part of this Decision.

In this case, please see below: "Important information about some of the ingredients of Diacomit".
For a detailed description of the commitment please see Annex C.
For a full description of the dosages, please see the Package Leaflet.
For the full description of the side effects reported with Actraphane, please see the Package Leaflet.
For the full description of all side effects reported with Corlentor, please see the Package Leaflet.
As for sustainability please see response above (c).
As regards the role of direct budget support, please see comments to paragraphs 36.
38.